Younger Children Develop Higher Effector Antibody Responses to SARS-CoV-2 Infection

BACKGROUND: The basis of the less severe clinical presentation of coronavirus disease 2019 (COVID-19) in children as compared with adults remains incompletely understood. Studies have suggested that a more potent boosting of immunity to endemic common cold coronaviruses (HCoVs) may protect children....

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasi, Lisa, Thiriard, Anais, Heyndrickx, Leo, Georges, Daphnée, Van den Wijngaert, Sigi, Olislagers, Véronique, Sharma, Shilpee, Matagne, André, Ackerman, Margaret E, Ariën, Kevin K, Goetghebuer, Tessa, Marchant, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709628/
https://www.ncbi.nlm.nih.gov/pubmed/36467295
http://dx.doi.org/10.1093/ofid/ofac554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709628/
https://www.ncbi.nlm.nih.gov/pubmed/36467295
http://dx.doi.org/10.1093/ofid/ofac554

Ejemplares similares